Tuft Cells Inhibit Pancreatic Tumorigenesis In Mice By Producing Prostaglandin D2

Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2

American Pancreatic Association

RNA binding protein DDX5 regulates microbial repertoire and disease in the intestine

Gastroenterology at BMJ

Revised pathology classification of pancreatic cancer predicts patient survival

The role of phosphoinositides in Parkinson’s disease pathology

Inhibition of gamma-Secretase Activity Inhibits Tumor Progression...

The roles of spastin and katanin in microtubule severing

Pancreatic Tumor generation and T Cell Cytotoxicity characterization | Protocol Preview

JoVE (Journal of Visualized Experiments)

Issues in fetal tissue transplantation for Parkinson's disease

Characterising SVs in acute myeloid leukemia using low depth nanopore sequencing - Touati Benoukraf

Oxford Nanopore Technologies

Transplantation: Pancreatic Islets Into Kidney Capsule Of Diabetic Mice l Protocol Preview

JoVE (Journal of Visualized Experiments)

Altogen Biosystems In Vitro L6 Transfection Tutorial

Altogen Biosystems

Kathy DelGiorno Full Interview – Pancreatic Cancer

Vanderbilt University

miR-31 is a major modulator of mouse intestinal stem cells during regeneration and tumorigenesis

Cédric Renancio

Dirk Sieger - Tumor initiating cells in the brain

Maturation-Human Embryonic Stem Cell To Pancreatic Insulin Producing Cells l Protocol Preview

JoVE (Journal of Visualized Experiments)

Using Sunitinib in Pancreatic Neuroendocrine Tumors (PNETs)

Growing tissue stem cells into organoids and tumeroids: Predictive assay development

Why is pancreatic cancer so hard to treat?

System For Ex Vivo Culturing Of Embryonic Pancreas l Protocol Preview

JoVE (Journal of Visualized Experiments)

Dr. Laber on the PRODIGE 35-PANOPTIMOX Trial in Metastatic Pancreatic Cancer